Phosphagenics raising cash for R&D
Australian biotech company Phosphagenics is looking to raise A$11.25 million in a share placement to fund its core R&D programme and other expenses.
News, Analysis & Insights on Nutrition, Supplements, and Health
Australian biotech company Phosphagenics is looking to raise A$11.25 million in a share placement to fund its core R&D programme and other expenses.
The UK's poor dietary habits are costing its health service an annual £6 billion (€8.9bn) - three times as much as the financial toll from smoking - suggests a new study.
BioCell Technologies has revamped its bovine-derived CMO (cetyle myristoleate) ingredient for joint health, offering a powder at a higher concentration than previously and a new oil that extends its applications.
Australia's dairy industry will spend $850,000 on research to find novel milk proteins that could be used in functional foods to improve nutrition and combat major diseases.
High fat-low carb diets, such as the once-trendy Atkins diet, appear to negatively impact the heart's energy stores, shows new research presented in the US this week.
Ocean Nutrition Canada has developed the technology to add omega-3 to chews without them tasting fishy, and is broadening out its ingredients-only business model to supply them on a bulk basis.
Men who consume a lot of calcium may have a higher risk of developing prostate cancer, concludes new research.